Physician profile
Robert J Allen
NPI 1023251287
$1,656.21
in general payments reported to CMS, 2019-2025
12 companies · $642 in 2025
The $642 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.45 · 2020: $39.57 · 2021: $44.52 · 2022: $102 · 2023: $168 · 2024: $576 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $615.45 | 2024-2025 | |
| Axogen | $205.77 | 2025 | |
| Kerecis Limited | $186.89 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tela Bio, INC. | $168.23 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Depuy Synthes Sales INC. | $143.38 | 2024 | Na, Trumatch |
| Medical Device Business Services, INC. | $78.10 | 2019-2022 | |
| Somavac Medical Solutions, INC. | $75.00 | 2022 | |
| Baxter Healthcare | $72.50 | 2019-2020 | |
| Integra Lifesciences Corporation | $38.57 | 2025 | Neuragen, Primatrix, Codman Certas |
| Kls-Martin L.P. | $27.78 | 2024 | |
| Allergan, INC. | $25.27 | 2021 | |
| Davol INC. | $19.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.